Zobrazeno 1 - 10
of 18
pro vyhledávání: '"James Garvin"'
Autor:
Zhezhen Jin, Wallace Bourgeois, Monica Bhatia, Laurie Davis, Prakash Satwani, Angela Ricci, Larisa Broglie, Jenny Ruiz, Diane George, James Garvin, Matthew Hall
Publikováno v:
Bone Marrow Transplantation. 55:1421-1429
Complications following allogeneic hematopoietic cell transplantation (alloHCT) continue to be a significant challenge that often result in significant morbidity/mortality and increased healthcare utilization and cost. In this study, we analyzed the
Autor:
Larisa Broglie, Diane George, Prakash Satwani, James Garvin, Angela Ricci, Matthew Hall, Zhezhen Jin, Monica Bhatia
Publikováno v:
Bone Marrow Transplantation. 55:384-392
The impact of AGVHD on healthcare utilization and cost is not well described. In this retrospective single center cohort study of 240 pediatric patients, we analyzed cost, healthcare utilization and patient outcomes for the first year post-alloHCT. C
Autor:
Diane George, Zhezhen Jin, Prakash Satwani, Matthew Hall, James Garvin, Monica Bhatia, Angela Ricci, Sonal Rastogi
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1253-1259
The literature on the impact of cytomegalovirus (CMV)-related hospitalization in pediatric allogeneic hematopoietic cell transplantation (alloHCT) recipients is limited. The aim of this study was to determine utilization and outcomes of CMV-related h
Autor:
Zhezhen Jin, Prakash Satwani, Monica Bhatia, Courtney Baker, Marc D Foca, James Garvin, Holly M. Wobma, Alicia K. Chang, Diane George
Publikováno v:
Pediatric transplantationREFERENCES. 25(4)
BACKGROUND HCT leaves patients in a relative state of immune deficiency both during their initial transplant admission and for several years following discharge. NTM are generally harmless colonizers of the outside environment, but for immunocompromi
Autor:
Justine M. Kahn, Jenny Ruiz, Zhezhen Jin, Prakash Satwani, James Garvin, Diane George, Larisa Broglie, Monica Bhatia
Publikováno v:
Transplantation and cellular therapy. 27(1)
Identifying which patients are at high risk for transplant-related mortality, prior to allogeneic hematopoietic cell transplantation (alloHCT), is crucial both to guide decision making with patients and families and to inform the alloHCT approach. Th
Autor:
Susan Whittier, Marc Foca, Monica Bhatia, Zhezhen Jin, Mary Laird, Rahul Vasudev, Michelle Kolb, Lisa Saiman, Anya Levinson, James Garvin, Andrew L. Kung, Mahvish Qureshi, Alicia K. Chang, Sharon Schwartz, Diane George, Phyllis Della-Latta, Prakash Satwani
Publikováno v:
American Journal of Infection Control. 44:1650-1655
Introduction There are only few reports describing the influence of central line-associated bloodstream infection (CLABSI) prevention strategies on the incidence of bacterial bloodstream infections (BBSIs). Methods We performed a retrospective cohort
Autor:
Andrew L. Kung, Justine M. Kahn, Prakash Satwani, Zhezhen Jin, Michelle Kolb, James Garvin, Katharine Offer, Diane George, Monica Bhatia
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:957-961
Tacrolimus (FK506) is a calcineurin inhibitor and is an essential component of many immunosuppressive regimens. The oral bioavailability of tacrolimus may be affected by many factors, including patient age and gender, as well as by drug-drug interact
Autor:
Diane George, Zhezhen Jin, Prakash Satwani, James Garvin, Matthew Hall, Wallace Bourgeois, Angela Ricci, Monica Bhatia
Publikováno v:
Bone marrow transplantation. 54(5)
The costs associated with allogeneic hematopoietic cell transplantation (alloHCT) are high. Differences in costs and healthcare utilization among potential donor sources for alloHCT are not well characterized in pediatric recipients of alloHCT. One p
Autor:
Jean Sosna, Prakash Satwani, Esra Karamehmet, Diane George, Leah Violago, Andrew L. Kung, Evelyn Rustia, Zhezhen Jin, Chalitha Robinson, Monica Bhatia, Marc Foca, James Garvin
Publikováno v:
Pediatric Transplantation. 19:737-744
HHV-6 is an evolving pathogen in the field of AlloHCT. However, the impact of HHV-6 on AlloHCT outcomes remains to be elucidated. We studied the incidence and clinical impact of HHV-6 viremia in children following AlloHCT. One hundred consecutive chi
Autor:
Chalitha Robinson, Esra Karamehmet, Prakash Satwani, Diane George, Michelle Kolb, Andrew L. Kung, Zhezhen Jin, Katharine Offer, James Garvin, Jean Sosna, Monica Bhatia
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(3):496-502
Only a few studies in children have evaluated the efficacy of prophylactic regimens using tacrolimus on acute graft-versus-host disease (aGVHD). As a result, optimal tacrolimus levels in children after matched sibling donor allogeneic hematopoietic c